Gene · 6480
Papers1,665
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,665
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Potential of Siglecs and Sialic Acids as Biomarkers and Therapeutic Targets in Tumor Immunotherapy. | Cancers (Basel) | 2024 | 38254780 | PubTator, text mining | PubMed |
| Exploring the relationship between metabolism and immune microenvironment in osteosarcoma based on metabolic pathways. | J Biomed Sci | 2024 | 38212768 | PubTator, text mining | PubMed |
| Protein cargo in extracellular vesicles as the key mediator in the progression of cancer. | Cell Commun Signal | 2024 | 38200509 | PubTator, text mining | PubMed |
| IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition. | Nat Commun | 2024 | 38195739 | PubTator, text mining | PubMed |
| Identification of therapeutic targets and prognostic biomarkers in the Siglec family of genes in tumor immune microenvironment of sarcoma. | Sci Rep | 2024 | 38182638 | PubTator, text mining | PubMed |
| Deciphering roles of protein post-translational modifications in IgA nephropathy progression and potential therapy. | Aging (Albany NY) | 2024 | 38175721 | PubTator, text mining | PubMed |
| Mucin1 as a potential molecule for cancer immunotherapy and targeted therapy. | J Cancer | 2024 | 38164273 | PubTator, text mining | PubMed |
| Nanointegrative Glycoengineering-Activated Necroptosis of Triple Negative Breast Cancer Stem Cells Enables Self-Amplifiable Immunotherapy for Systemic Tumor Rejection. | Adv Healthc Mater | 2024 | 38154036 | PubTator, text mining | PubMed |
| Understanding Fc function for rational vaccine design against pathogens. | mBio | 2024 | 38112418 | PubTator, text mining | PubMed |
| Identification of a buried β-strand as a novel disease-related motif in the human polysialyltransferases. | J Biol Chem | 2024 | 38103644 | PubTator, text mining | PubMed |
| Circ_ST6GAL1-mediated competing endogenous RNA network regulates TGF-β1-stimulated matrix Metalloproteinase-13 expression via Runx2 acetylation in osteoblasts. | Noncoding RNA Res | 2024 | 38035043 | PubTator, text mining | PubMed |
| CCCTC-binding factor: the specific transcription factor of β-galactoside α-2,6-sialyltransferase 1 that upregulates the sialylation of anti-citrullinated protein antibodies in rheumatoid arthritis. | Rheumatology (Oxford) | 2024 | 37326830 | PubTator, text mining | PubMed |
| Progress in pH-Sensitive sensors: essential tools for organelle pH detection, spotlighting mitochondrion and diverse applications. | Front Pharmacol | 2023 | 38269286 | PubTator, text mining | PubMed |
| Comprehensive Overview the Role of Glycosylation of Extracellular Vesicles in Cancers. | ACS Omega | 2023 | 38144130 | PubTator, text mining | PubMed |
| 6'-sialyllactose ameliorates the ototoxic effects of the aminoglycoside antibiotic neomycin in susceptible mice. | Front Immunol | 2023 | 38130726 | PubTator, text mining | PubMed |
| In silico identification and functional prediction of differentially expressed genes in South Asian populations associated with type 2 diabetes. | PLoS One | 2023 | 38096208 | PubTator, text mining | PubMed |
| Glycation Interferes with the Expression of Sialyltransferases and Leads to Increased Polysialylation in Glioblastoma Cells. | Cells | 2023 | 38067186 | PubTator, text mining | PubMed |
| Human-specific features and developmental dynamics of the brain N-glycome. | Sci Adv | 2023 | 38055821 | PubTator, text mining | PubMed |
| Exploiting Substrate Specificities of 6-O-Sulfotransferases to Enzymatically Synthesize Keratan Sulfate Oligosaccharides. | JACS Au | 2023 | 38034954 | PubTator, text mining | PubMed |
| Integrated systems biology approach identifies gene targets for endothelial dysfunction. | Mol Syst Biol | 2023 | 38031960 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6480/papers?page=8